KAT2A was highly expressed in pancreatic cancer; its mediated expression of 14-3-3ζ and β-catenin has been shown to promote glycolysis, proliferation, epithelial-mesenchymal transition, and migration in pancreatic cancer cells [36]. The gene discussed is KAT2A; the disease is familial pancreatic carcinoma.